Works in Molecular & Clinical Oncology, 2020, Vol 13, Issue 6


Results: 27
    1
    2
    3
    4
    5
    6
    7
    8
    9

    Interleukin 25 (IL-25) expression in cholangiocarcinoma.

    Published in:
    Molecular & Clinical Oncology, 2020, v. 13, n. 6, p. N.PAG, doi. 10.3892/mco.2020.2154
    By:
    • Kaewsarabhumi, Supakit;
    • Proungvitaya, Tanakorn;
    • Limpaiboon, Temduang;
    • Tippayawat, Patcharaporn;
    • Tummanatsakun, Doungdean;
    • Titapun, Attapol;
    • Sa-Ngaimwibool, Prakasit;
    • Proungvitaya, Siriporn
    Publication type:
    Article
    10
    11
    12
    13
    14
    15

    Oral intake of royal jelly improves anti-cancer effects and suppresses adverse events of molecular targeted therapy by regulating TNF-α and TGF-β in renal cell carcinoma: A preliminary study based on a randomized double-blind clinical trial.

    Published in:
    Molecular & Clinical Oncology, 2020, v. 13, n. 6, p. N.PAG, doi. 10.3892/mco.2020.2148
    By:
    • Miyata, Yasuyoshi;
    • Araki, Kyohei;
    • Ohba, Kojiro;
    • Mastuo, Tomhiro;
    • Nakamura, Yuichiro;
    • Yuno, Tsutomu;
    • Mukai, Yuta;
    • Otsubo, Asato;
    • Mitsunari, Kensuke;
    • Mochizuki, Yasushi;
    • Sakai, Hideki
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27